Form 8-K - Current report:
SEC Accession No. 0000921895-21-001683
Filing Date
2021-06-22
Accepted
2021-06-22 16:34:47
Documents
1
Period of Report
2021-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8k12566003_06212021.htm 8-K 28558
  Complete submission text file 0000921895-21-001683.txt   29829
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 211035764
SIC: 2834 Pharmaceutical Preparations